Bay, Pierre http://orcid.org/0000-0002-6751-2110
Audureau, Etienne
Préau, Sébastien
Favory, Raphaël
Guigon, Aurélie
Heming, Nicholas
Gault, Elyanne
Pham, Tài
Chaghouri, Amal
Turpin, Matthieu
Morand-Joubert, Laurence
Jochmans, Sébastien
Pitsch, Aurélia
Meireles, Sylvie
Contou, Damien
Henry, Amandine
Joseph, Adrien
Chaix, Marie-Laure
Uhel, Fabrice
Roux, Damien
Descamps, Diane
Emery, Malo
Garcia-Sanchez, Claudio
Levy, David
Burrel, Sonia
Mayaux, Julien
Kimmoun, Antoine
Hartard, Cédric
Pène, Frédéric
Rozenberg, Flore
Gaudry, Stéphane
Brichler, Ségolène
Guillon, Antoine
Handala, Lynda
Tamion, Fabienne
Moisan, Alice
Daix, Thomas
Hantz, Sébastien
Delamaire, Flora
Thibault, Vincent
Souweine, Bertrand
Henquell, Cecile
Picard, Lucile
Botterel, Françoise
Rodriguez, Christophe
Dessap, Armand Mekontso
Pawlotsky, Jean-Michel
Fourati, Slim
de Prost, Nicolas
Razazi, Keyvan
Bellaïche, Raphaël
Azoulay, Elie
Timsit, Jean-François
Voiriot, Guillaume
de Montmollin, Nina
Marot, Stéphane
Gasperment, Maxime
Urbina, Tomas
Oufella, Hafid Ait
Fofana, Eric Maury Djeneba Bocar
Luyt, Charles-Edouard
Annane, Djillali
Meziani, Ferhat
Jandeaux, Louis-Marie
Fafi-Kremer, Samira
Darreau, Cédric
Thomin, Jean
Dartevel, Anaïs
Larrat, Sylvie
Schvoerer, Evelyne
La Combe, Béatrice
Haouisee, Séverine
Hraeich, Sami
Fournier, Pierre-Edouard
Colson, Philippe
Canet, Emmanuel
Imbert, Berthe Marie
Thiery, Guillaume
Pillet, Sylvie
Coudroy, Rémy
Leveque, Nicolas
Saccheri, Clément
Giordanengo, Valérie
Klouche, Kada
Tuaillon, Edouard
Aubron, Cécile
Tran, Adissa
Tadié, Jean-Marc
Plantier, Jean-Christophe
Vallet, Sophie
,
Funding for this research was provided by:
The SEVARVIR study has been funded by the EMERGEN consortium—ANRS Maladies Infectieuses Emergentes (ANRS0153)
Article History
Received: 1 March 2024
Accepted: 15 April 2024
First Online: 24 April 2024
Declarations
:
: The study was approved by the Comité de Protection des Personnes Sud-Méditerranée I (N° EudraCT/ID-RCB: 2021-A02914-37). Informed consent was obtained from all patients or their relatives.
: S.F. has served as a speaker for GlaxoSmithKline, AstraZeneca, MSD, Pfeizer, Cepheid and Moderna. J.-M.P. has served as an advisor or speaker for Abbvie, Arbutus, Assembly Biosciences, Gilead and Merck. E.A. has received fees for lectures from Alexion, Sanofi, Gilead and Pfizer. His hospital has received research grant from Pfizer, MSD and Alexion. D.D. served as an advisor for Gilead-Sciences, ViiV Health care, Janssen-Cilag et MSD. F.P. served as an advisor for Gilead; he also received research grant from Alexion. N.D.P has served as an advisor or speaker for Moderna and AstraZeneca. Other authors have no conflict of interest to disclose.